Illumina snags software for genomics lab

GenoLogics Life Sciences Software has tied up a deal with DNA sequencing powerhouse Illumina ($ILMN), which has inked a subscription agreement for GenoLogics's Clarity LIMS product. Illumina plans to use the Victoria, Canada-based company's software among other systems in its clinical certified lab where Illumina sequences genomes. Item

Suggested Articles

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

The $58 million financing round represents biopharma industry's growing interest in genomics data.